Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Evolocumab Lowers LDL-C in Diabetic Patients on Maximum StatinsIn patients with type 2 diabetes and hyperlipidemia or mixed dyslipidemia on a maximally tolerated statin, treatment with evolocumab lowers low-density-lipoprotein cholesterol (LDL-C) and improves levels of other lipids, researchers say.
Reuters Health Information, April 2019
Diabetes Has Lethal Consequences in AsiaPooled analysis that included over 1 million adults showed substantially increased risk for all-cause and cause-specific death among those with diabetes; Asian-specific management programs are needed.
Medscape Medical News, April 2019
FDA's Added-Sugar Labeling Policy to Pay Sweet DividendsThe first-of-its-kind study projects striking reductions in cardiovascular disease and type 2 diabetes, coupled with billions in cost savings after implementation of an added-sugar labeling policy.
Calling Time on the Failure in Heart Failure Optimal medical therapy and recent advances show that heart failure is preventable and not obligatory, Clyde Yancy tells Bob Harrington.
ISCHEMIA: Do Baseline Data Hint at Triumph for OMT?The success of OMT and the decline of patients with severe ischemia may make it difficult for ISCHEMIA to show benefit for revascularization, predicts Mayo Clinic's Raymond Gibbons, MD.
